John Ryals

John A. Ryals, Ph.D. Short Bio Education : B.A. Biology, Chemistry and Music, University of North Texas, 1977 M.S. Molecular Biology, University of Texas at Dallas, 1980 Ph.D. Molecular Biology, University of Texas at Dallas, 1982 Postdoctoral Scientist, Institute of Molecular Biology, University of Zurich, 1983-1984 Professional Experience: Ciba Geigy, Agricultural Biotechnology Research Unit 1985 to 1997. Started as a Research Scientist and Group Leader and took over as head of Ag Biotech Research in 1993. Was also VP of Intellectual Property and Member of the Executive Board of Ciba Seeds. (Ciba merged with Sandoz to become Novartis and later merged with Astra Zeneca Ag Group to become Syngenta) Founding CEO and President of Paradigm Genetics and Member of the Board of Directors from October 1997 to March 2002. Paradigm Genetics was developed as a high throughput functional genomics company focused in Ag Biotech. The company raised about $115 million over this time with 3 private and 2 public offerings. The IPO was completed in May 2000 on NASDAQ listed as PDGM. There were major development programs established with Bayer Crop Science and Monsanto. Founding CEO and President and Board member of Metabolon from April 2002 to May 2018. Retired in May 2018 as CEO and now have the title of Founder, Board Member and Chairman Emeritus. Metabolon was started to develop the nascent field of Metabolomics. It is now recognized as the premier company in the fast-growing metabolomics space. The company has a fee for service division that processed 7000 research projects bringing in over $250 million in revenue. We raised $87 million in private investment capital over 10 financing events. Metabolon also developed a Population Health Division doing about $10 million last year and a Precision Medicine Division doing about $5 million last year. Co-Founded AgBiome September 2012 and Member of the Board of Directors. AgBiome is using the soil microbiome to develop products for Crop Protection, Agriculture and other industries. They have established several partnerships with major ag companies (they have not made these agreements public). The Company has raised about $115 million in 3 private rounds of financing. Currently consulting with AgBiome on moving the Crop Protection subsidiary, AgBiome Innovations, to an independent company. In 2002, assisted Mike Koziel and his team start the agbiotech company, Athenix, and get initial funding. Served on the Board from about 2003 to 2007 and served as a consultant during most of that time. Athenix sold to Bayer for $400 million in 2009.